Final ID: Mo4159
Zhu Yunpeng, Guo Zhigang, Zhu Dan, Zhang Xiquan, Chen Liangwan, Redfors Bjorn, Sandner Sigrid, Gaudino Mario, Tu Shengxian, Zhao Qiang, Cheng Zhaoyun, Zhao Yuan, Zhang Wei, Han Lin, Zhang Chengxin, Yang Sumin, Ma Liang, Qiao Chenhui
Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterolVafai Scott, Fiedorek Fred, Karsten Verena, Jensen Chelsey, Falzone Richard, Lister Troy, Stolz Leslie, Khera Amit, Kathiresan Sekar, Bellinger Andrew